Navigation Links
York physicists offer novel insight into experimental cancer treatment
Date:7/15/2013

aid: "Through our study we have produced the first comprehensive assessment of how the heating effect in magnetic hyperthermia works. We are now in a position where we can do further work to calculate accurately the dose of magnetic nanoparticles and length of treatment required."

For the study, the researchers used magnetic nanoparticles produced by a new technique by Liquids Research Ltd, which was developed under the EU project MULTIFUN (Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer). The nanoparticles are very uniform in size and well separated, which enabled detailed experiments to be performed which broadly confirmed the accuracy of the calculations.

Dr Vijay Patel, Director of Liquids Research Ltd, said: "The development of this new theory coincided with our work on the new process to fabricate the nanoparticles enabling us to 'design' almost ideal particles for this application."


'/>"/>

Contact: Caron Lett
caron.lett@york.ac.uk
44-019-043-22029
University of York
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Seeing is believing: Biologists and physicists produce revealing images of cell organization, behavior
2. Experts Offer Advice After Yankee Pitchers Trampoline Injury
3. Mayo Clinic offers newly approved treatment for acid reflux disease
4. Here Are Fruits, Veggies That Offer Best Bang for Your Buck
5. Wilderness Medicine founder offers health tips for summer season
6. Ice Cream Headaches Might Offer Clues to Migraines
7. Botox Offers Little Relief for Migraine, Study Finds
8. Novel drug candidates offer new route to controlling inflammation
9. Prosthetic retina offers simple solution to restoring sight
10. Study Offers Ways to Decrease Use of Restraints at Nursing Homes
11. Cabazitaxel can offer an advantage in certain patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... Liverpool, OH (PRWEB) May 22, 2015 ... announced that Kyle Johnson, the health system’s Chief Financial ... other interests. Johnson has served as the company CFO ... Wesley West will be joining the health system as ... on an interim basis, while the Board of Trustees ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
(Date:5/22/2015)... 2015 Carnegie Science Center ... a new partnership to develop BodyTech, a dynamic, three-pronged ... initiative includes a new exhibit at the Science Center ... and a new traveling science show, Anatomy Adventure, which ... , Designed to explore a wide range of ...
(Date:5/22/2015)... Power Systems is proud to announce the ... season. Drobeck is in his second year of racing in ... the Missoula Fire Department in Missoula, MT. He entered the ... During his career, he has had 15 1st Place finishes. ... 10 finishes in all seven of his 2014 races, including ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... Scientists at the ,University of North Carolina at Chapel ... plays a central role in the formation of new blood ... new blood vessel formation, or angiogenesis, is seriously impaired without ... 2011 in the journal Blood , was led by ...
... prevention trial that has been evaluating two antiretroviral (ARV)-based approaches ... daily use of one of two different ARV tablets or ... The decision to discontinue use of the gel, which contains ... study data concluded tenofovir gel was not effective in preventing ...
... -- Patients hospitalized for autoimmune disorders, like rheumatoid arthritis ... life-threatening pulmonary embolism, a clot in a main artery of ... 25 in The Lancet , researchers warned that steps ... to the hospital for autoimmune diseases. , , In conducting ...
... CHICAGO By combining conventional medical imaging with some ... blockbusters, researchers are offering new hope to victims of ... human face transplantation, led by Darren M. Smith, M.D., ... Center (UPMC), were presented today at the annual meeting ...
... News) -- Racism is similar to trauma in how ... the United States, a new analysis finds. An ... 18,000 black adults concluded that there are common responses ... that is expressed as physical pain), interpersonal sensitivity and ...
... should be able to choose where they give birth, concludes ... first-time mums who opt for a home birth are at ... low in all birth settings. The researchers say their ... pregnancies a choice of birth setting" and will enable women ...
Cached Medicine News:Health News:Cell molecule identified as central player in the formation of new blood vessels 2Health News:Cell molecule identified as central player in the formation of new blood vessels 3Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 2Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 3Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 4Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 5Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 6Health News:Tenofovir gel dropped from HIV prevention trial in women because it was not effective 7Health News:Autoimmune Woes May Raise Risk for Lung Clots 2Health News:Integrated 3-D imaging facilitates human face transplantation 2Health News:Integrated 3-D imaging facilitates human face transplantation 3Health News:Pregnant women at low risk of complications can safely be offered a choice of where to give birth 2
(Date:5/22/2015)... Electrophysiologist Kevin Makati, M.D. with St. ... Boston, MA to speak about ... Society conference. These scientific sessions drew more than ... people and technology that propel their specialty forward. ... invasive cardiac operation that combines the expertise of ...
(Date:5/22/2015)...  The U.S. Food and Drug Administration,s (FDA) ... biosimilar product approved in the United ... the contract manufacturing organization (CMO) industry, according to ... to the production of small-molecular drugs and lacks ... healthcare market research publisher,s report, Biopharmaceutical and ...
(Date:5/22/2015)... , May 22, 2015 According ... Market by Product (Consumables, Instruments, Services), by Test Type ... Chromatography, Flow Cytometry), by End Users - Global Forecast ... Market is expected to reach $736.85 Million by 2020 ... of 10.25%. Browse 71 market data ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... research at SRI International, scientists evaluating new drug targets against ... that could rapidly eliminate infections and potentially shorten treatment time. ... B, found in bacteria that cause TB infections. ... A and gyrase B. Although gyrase A is often the ...
... 29, 2011   Acuo Technologies ® ... for intelligent medical image lifecycle management and data ... has selected the Universal Clinical Platform (UCP3) ... UCP3 will replace Fairview,s existing PACS archives while ...
Cached Medicine Technology:SRI Researchers Validate Preclinical Effectiveness of Tuberculosis Drug Target that Could Shorten Treatment Time 2Acuo Technologies Announces Vendor Neutral Archiving Contract with Fairview Health Services 2Acuo Technologies Announces Vendor Neutral Archiving Contract with Fairview Health Services 3
Stainless steel bone clamp....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
Straight double action bone cutting rongeur....
Beuse Zygomatic Arch Awl with slightly curved tip....
Medicine Products: